Female Health (NAS: FHCO) is expected to report Q4 earnings around Nov. 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Female Health's revenues will increase 33.9% and EPS will wane -35.3%.
The average estimate for revenue is $9.5 million. On the bottom line, the average EPS estimate is $0.11.
Last quarter, Female Health reported revenue of $8.7 million. GAAP reported sales were much higher than the prior-year quarter's $3.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.09. GAAP EPS of $0.09 for Q3 were much higher than the prior-year quarter's $0.01 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 61.2%, 960 basis points better than the prior-year quarter. Operating margin was 32.4%, 1,960 basis points better than the prior-year quarter. Net margin was 29.5%, 1,770 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $34.6 million. The average EPS estimate is $0.34.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 285 members out of 294 rating the stock outperform, and nine members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 55 give Female Health a green thumbs-up, and give it a red thumbs-down.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Female Health. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.
Add Female Health to My Watchlist.
The article Can Female Health Beat These Numbers? originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.